Prescient Therapeutics Limited Stock
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
03:01:03 29/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.0550 AUD | +5.77% |
|
-1.79% | -34.52% |
| 23/10 | Prescient Therapeutics Limited Announces Management Changes, Effective October 23, 2026 | CI |
| 21/10 | Prescient Therapeutics Limited - Special Call |
| Market Cap | 59.48M 41.87M 37.57M 34.73M 31.46M 58.77M 3.99B 415M 165M 2.09B 157M 154M 6.62B | P/E 2025 |
-4.84x | P/E 2026 | -8.94x |
|---|---|---|---|---|---|
| Enterprise Value | 50.66M 35.66M 31.99M 29.58M 26.79M 50.05M 3.4B 354M 141M 1.78B 134M 131M 5.64B | EV / Sales 2025 |
6.54x | EV / Sales 2026 | 16x |
| Free-Float |
94.89% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PTX | Delayed | |
Deutsche Boerse AG
| UDD | Delayed |
Last Transcript: Prescient Therapeutics Limited
| 1 day | +5.77% | ||
| 1 week | -1.79% | ||
| Current month | -17.91% | ||
| 1 month | -23.61% | ||
| 3 months | -32.10% | ||
| 6 months | +7.84% | ||
| Current year | -34.52% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 20/01/2025 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 30/03/2025 |
Allen Ebens
BRD | Director/Board Member | - | 01/06/2020 |
Ellen Feigal
BRD | Director/Board Member | 71 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/26 | Buy | Director | 200,000 | 0.0175% | ||
| 30/9/26 | Buy | Chairman | 153,846 | 0.0134% | ||
| 30/9/26 | Buy | Director | 76,923 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.77% | -1.79% | +12.24% | -3.51% | 41.87M | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +1.58% | +3.29% | +12.92% | +85.00% | 55.53B | |
| +1.83% | +1.78% | +13.05% | +105.26% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| -2.39% | +42.88% | +103.98% | +90.46% | 34.47B | |
| -2.72% | -0.44% | +23.18% | -10.77% | 24.23B | |
| Average | +1.14% | +2.80% | +48.37% | +146.07% | 39.26B | |
| Weighted average by Cap. | +0.93% | +3.49% | +49.43% | +160.65% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.36M 3.07M 2.75M 2.54M 2.3M 4.3M 292M 30.42M 12.11M 153M 11.51M 11.27M 485M | 3.45M 2.43M 2.18M 2.02M 1.83M 3.41M 231M 24.1M 9.6M 121M 9.12M 8.92M 384M |
| Net income | -7.32M -5.15M -4.62M -4.28M -3.87M -7.24M -491M -51.13M -20.36M -257M -19.34M -18.94M -816M | -7M -4.93M -4.42M -4.09M -3.7M -6.92M -470M -48.89M -19.47M -246M -18.5M -18.11M -780M |
| Net Debt | -6.93M -4.88M -4.38M -4.04M -3.66M -6.84M -464M -48.36M -19.26M -243M -18.3M -17.91M -772M | -8.83M -6.21M -5.57M -5.15M -4.67M -8.72M -592M -61.62M -24.54M -310M -23.31M -22.82M -983M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $0.0550 | +5.77% | 17,580 |
| 28/10/26 | $0.0520 | -3.70% | 457,731 |
| 27/10/26 | $0.0540 | +5.88% | 271,970 |
| 26/10/26 | $0.0510 | -5.56% | 1,589,874 |
| 23/10/26 | $0.0540 | -3.57% | 886,759 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
